Fulcrum Asset Management LLP Merck & Co., Inc. Transaction History

Fulcrum Asset Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $2.23 Million - $2.39 Million	-17,975 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $779,353 - $873,604	-10,602 Reduced 37.1%	17,975 $1.38 Million
Q3 2021 Oct 19, 2021	BUY	$71.68 - $78.83 $2.05 Million - $2.25 Million	28,577 New	28,577 $1.99 Million
Q2 2021 Jul 13, 2021	BUY	$70.31 - $77.77 $0 - $0	0 New	0 $2.06 Million
Q2 2021 Jul 12, 2021	SELL	$70.31 - $77.77 $1.68 Million - $1.86 Million	-23,907 Closed	0 $2.06 Million
Q1 2021 Apr 21, 2021	BUY	$68.86 - $81.11 $1.65 Million - $1.94 Million	23,907 New	23,907 $1.7 Million

3,802

1.92B

13.4M

10.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Fulcrum Asset Management LLP, based on Form 13F filings with the SEC.

Stay updated on Fulcrum Asset Management LLP with notifications on news.